查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927373

经经皮冠状动脉旋磨术市场按产品类型、病变类型、最终用户和适应症划分－2026-2032年全球预测

Percutaneous Transluminal Coronary Rotational Atherectomy Market by Product Type, Lesion Type, End User, Indication - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年经皮冠状动脉旋磨术市场价值为 9,086 万美元，预计到 2026 年将成长至 1.0456 亿美元，年复合成长率为 12.71%，到 2032 年将达到 2.1007 亿美元。

关键市场统计数据
基准年 2025 9086万美元
预计年份：2026年 1.0456亿美元
预测年份 2032 2.1007亿美元
复合年增长率 (%) 12.71%

旋转动脉粥状硬化斑块切除术简介：全面介绍现代介入性心臟病学中的临床原理、器械发展历程和手术整合。

经皮冠状动脉旋磨术（PTC）是一种专门用于改善冠状动脉钙化斑块、便于器械输送并提高手术效果的血管内技术。该技术结合了机械减容、高速旋转磨钻以及辅助介入策略，旨在优化支架植入，并恢復传统球囊血管成形术无效病变的冠状动脉灌注。过去十年，技术的改进、磨钻工程的进步以及辅助引导和冲洗技术的提升，共同提高了PTC治疗复杂钙化病变的临床可靠性。

技术、影像和临床实践的发展趋势正在重新定义复杂冠状动脉介入治疗中旋切动脉粥状硬化斑块切除术的选择和实施方式。

冠状动脉旋动脉粥状硬化斑块切除术领域正经历着变革性的转变，这主要得益于技术创新、手术技巧的精进以及更广泛的临床应用。微型化和材料科学的进步催生了新一代的磨头和系统元件，这些组件在保持有效去除钙化病变的同时，显着提高了在复杂解剖结构中的操作灵活性。同时，血管内超音波和光学同调断层扫描（OCT）等影像技术的进步，使得病灶特征的精确表征成为可能，从而指导磨头的选择和手术策略的发展。

美国关税变化对医疗设备相关人员的营运影响：推动供应链重组、合约重新谈判和策略性在地化

美国近期关税调整为心血管器械製造商、经销商和采购机构带来了新的营运考量。进口关税和分类通讯协定的变化影响了通常在多个司法管辖区生产的零件的到岸成本，促使采购团队重新评估筹资策略和库存政策。因此，一些供应商已开始进行区域化生产并调整物流流程，以降低关税风险，并为医院系统和专科诊所维持价格竞争力。

分段分析揭示了产品组件、病变形态、临床适应症和治疗环境如何相互作用，从而影响器械选择和手术结果。

基于产品细分的洞察揭示了不同系统平台、耗材组件和特定尺寸钻头产品线中细微的性能驱动因素。诸如冲洗盒、导管导引线和旋转适配器等配件在手术安全性和效率方面发挥关键作用，而係统级特性则决定了与各种钻头轮廓的兼容性以及操作者的舒适度。在动脉粥状硬化斑块切除术钻头类别中，小型、中型和大型钻头的不同设计特性会影响病变矫正策略和与下游设备的兼容性，进而影响临床选择。

影响美洲、欧洲、中东和非洲以及亚太地区临床应用、供应链策略和培训重点的区域趋势

区域趋势对旋切动脉粥状硬化斑块切除术技术的应用、监管合规性和临床医生培训有显着影响。在美洲，成熟的介入治疗网路和先进的手术基础设施为先进动脉粥状硬化斑块切除术系统的应用提供了支持，而报销机制和大型医院集团的采购协议则影响着采购週期和资本支出。相较之下，在欧洲、中东和非洲地区，不同的法规环境和先进影像技术的普及程度差异影响着旋切术的普及率，凸显了模组化系统设计的重要性，这种设计能够适应不同的临床实践环境。

企业层面的竞争和策略趋势强调产品差异化、伙伴关係、证据产生以及对整个设备组合的全生命週期支持。

医疗器材产业的竞争格局由渐进式产品创新、策略联盟和以手术相容性和临床操作便利性为优先的商业化措施所驱动。製造商在诸如磨头材料科学、输送导管的柔软性以及与成像平台整合的介面等方面展开竞争，这些介面可在病灶形成过程中提供即时回馈。随着临床团队寻求能够缩短手术时间、提高安全裕度并融入现有导管室工作流程的器械，这些特性对于产品差异化的重要性日益凸显。

为确保永续应用，对医疗器材製造商和医疗系统提出具体建议：优先考虑创新、临床医生培训、合约柔软性和供应链韧性。

产业领导者应优先考虑提升设备与先进成像技术的兼容性、简化操作人员的工作流程，并确保供应链的韧性，以减少贸易中断的影响。投资于临床医生培训，包括实践模拟和远端监控，将加速安全应用，并建立卓越中心，作为更广泛推广的参考范例。从商业性角度来看，建立灵活的合约模式和基于价值的提案，兼顾手术总成本和临床疗效，可以增强您在医院采购团队中的地位。

为了确保分析的严谨性，我们采用了稳健的混合方法研究通讯协定，该方案结合了与临床医生的直接接触、二次临床文献审查和数据三角验证。

本研究途径结合了与介入性心臟病专家、导管检查室经理和采购人员的结构化一手调查，以及对临床文献、医疗设备监管申报文件和操作指南的二手分析。一手资料包括深度访谈和结构化调查问卷，旨在深入了解临床决策驱动因素、装置偏好和操作限制。二手资讯则着重于同侪审查的证据和共识声明，这些证据和声明提供了最佳实践，以支持临床路径、技术规范和监管趋势。

对决定冠状动脉旋磨术目前及近期发展方向的临床、技术和商业性动态进行综合分析

总之，经经皮冠状动脉旋磨术在设备不断改进、影像融合技术增强以及临床医生经验日益丰富的支持下，在复杂钙化冠状动脉疾病的治疗中发挥越来越重要的作用。产品创新、手术标准化和采购趋势的演变正在重塑医疗机构在各种临床环境中选择和实施斑块消融策略的方式。那些能够将产品开发与临床医生需求相结合、投资于可扩展的培训并积极应对供应链脆弱性的相关人员，将更有利于提供临床价值和保障业务连续性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 经经皮冠状动脉旋磨术市场（依产品类型划分）

  • 配件
    • 闪光盒
    • 导管导引线
    • 旋转适配器
  • 动脉粥状硬化斑块切除术棒
    • 大酒吧
    • 中酒吧
    • 小酒吧
  • 动脉粥状硬化斑块切除术系统

第九章 经经皮冠状动脉旋磨术市场（依病变类型划分）

  • 轻度钙化
  • 中度钙化
  • 非钙化性病变
  • 严重钙化

第十章 经经皮冠状动脉旋磨术市场（依最终用户划分）

  • 门诊手术中心
  • 心臟诊所
  • 医院

第十一章 经经皮冠状动脉旋磨术市场（依适应症划分）

  • 非ST段上升型心肌梗塞（NSTEMI）
  • 稳定性心绞痛
  • ST段上升型心肌梗塞
  • 不稳定型心绞痛

第十二章 经经皮冠状动脉旋磨术市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 经经皮冠状动脉旋磨术市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国经经皮冠状动脉旋磨术市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国经皮冠状动脉旋磨术市场

第十六章 中国经皮冠状动脉旋磨术市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cook Medical LLC
  • INVAMED
  • Koninklijke Philips NV
  • Medtronic PLC
  • NEScientific, Inc
  • NIPRO CORPORATION
  • RA Medical Systems, Inc.
  • Rotarex, SA by Becton, Dickinson and Company
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF381

The Percutaneous Transluminal Coronary Rotational Atherectomy Market was valued at USD 90.86 million in 2025 and is projected to grow to USD 104.56 million in 2026, with a CAGR of 12.71%, reaching USD 210.07 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 90.86 million
Estimated Year [2026] USD 104.56 million
Forecast Year [2032] USD 210.07 million
CAGR (%) 12.71%

Comprehensive introduction to rotational atherectomy that frames clinical rationale, device evolution, and procedural integration across contemporary interventional cardiology

Percutaneous transluminal coronary rotational atherectomy represents a specialized endovascular technique focused on modifying calcified coronary plaques to facilitate device delivery and improve procedural outcomes. The technique combines mechanical debulking using high-speed rotational burrs with adjunctive interventional strategies to optimize stent deployment and restore coronary perfusion in lesions that are resistant to conventional balloon angioplasty. Over the past decade, procedural refinements, engineering advances in burr geometry, and improvements in adjunctive guide and flush technologies have collectively raised clinical confidence in treating complex calcified disease.

Clinicians increasingly view this therapy as a targeted option for patients with severe calcification or lesion characteristics that limit crossing and expansion of standard devices. As a result, device design has evolved to emphasize deliverability, compatibility with advanced imaging, and control of particulate debris. Consequently, hospitals and specialty cardiac centers have introduced protocolized pathways to identify appropriate candidates and to integrate rotational atherectomy within hybrid treatment algorithms. These developments have reshaped procedural planning, operator training, and supply chain considerations for high-acuity cardiac programs.

Transformational currents in technology, imaging, and clinical practice that are redefining how rotational atherectomy is selected and performed in complex coronary interventions

The landscape of coronary rotational atherectomy is undergoing transformative shifts driven by technological innovation, refined procedural techniques, and broader clinical adoption patterns. Miniaturization and enhanced materials science have produced a new generation of burrs and system components that improve navigability through tortuous anatomy while maintaining effective calcific modification. Concurrently, imaging enhancements such as intravascular ultrasound and optical coherence tomography have enabled precise lesion characterization, which in turn informs burr selection and procedural strategy.

Beyond hardware, operator competency models have expanded with structured proctoring and simulation-based training that accelerate skill acquisition while reducing complication rates. Reimbursement and institutional protocols have adapted to incorporate multidisciplinary decision-making, where interventional cardiologists, imaging specialists, and vascular teams jointly determine the appropriateness of rotational atherectomy for complex lesions. As a result, the modality is transitioning from a niche rescue technique to a considered option within the armamentarium for calcified coronary disease, supported by iterative device improvements and evidence-informed practice patterns.

Operational repercussions of revised United States tariffs that are prompting supply chain realignment, contract renegotiation, and strategic localization for device stakeholders

Recent tariff adjustments in the United States have introduced new operational considerations for manufacturers, distributors, and purchasing organizations involved with cardiovascular devices. Changes in import duties and classification protocols have affected landed costs for components that are often manufactured across multiple jurisdictions, prompting procurement teams to reassess sourcing strategies and inventory policies. Consequently, some suppliers have initiated regional consolidation of manufacturing and adjusted logistics flows to mitigate tariff exposure and to preserve competitive pricing for hospital systems and specialty clinics.

In response, health systems and device providers have revisited vendor contracts to incorporate clauses addressing tariff volatility and to establish contingency plans for supply continuity. Moreover, the evolving duty landscape has influenced decisions regarding local assembly, compliance documentation, and product labeling to optimize customs treatment. For clinical programs, these shifts underscore the importance of visibility into supply chains and proactive collaboration with suppliers to maintain equipment availability, protect procedure scheduling, and sustain patient care pathways amid changing trade conditions.

Segment-driven analysis revealing how product components, lesion morphology, clinical indications, and care settings converge to influence device selection and procedural outcomes

Insights derived from product-based segmentation reveal nuanced performance drivers across system platforms, consumable components, and size-specific burr offerings. Accessories such as flush cassettes, guide wires, and rotational adapters play a pivotal role in procedural safety and efficiency, while system-level attributes determine compatibility with diverse burr profiles and operator ergonomics. Within the atherectomy burr category, differentiated design characteristics across small, medium, and large burrs influence lesion modification strategies and downstream device compatibility, thereby shaping choice at the point of care.

When the lesion-type segmentation is applied, clinical decision-making aligns with lesion morphology, where non-calcified and mildly calcified lesions may be managed conservatively or with adjunctive balloon strategies, while moderate to severe calcifications frequently necessitate ablative approaches to ensure luminal gain and stent expansion. End-user segmentation highlights distinct procurement and usage patterns: ambulatory surgical centers emphasize throughput and device portability, cardiac specialty clinics prioritize procedure-specific disposables and simplified inventory, and hospitals concentrate on comprehensive device ecosystems that support complex cases and backup capabilities. In parallel, indication-based segmentation across NSTEMI, stable angina, STEMI, and unstable angina underscores the need for rapid assessment, triage, and tailored device selection aligned to acute versus elective procedural contexts.

Regional dynamics shaping clinical adoption, supply chain strategies, and training priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories

Regional dynamics exert a pronounced influence on technology adoption, regulatory navigation, and clinician training for rotational atherectomy. In the Americas, established interventional networks and advanced procedural infrastructure support the integration of sophisticated atherectomy systems, while reimbursement frameworks and large hospital group purchasing arrangements shape procurement cycles and capital investments. Conversely, Europe, the Middle East & Africa present heterogeneous regulatory environments and variable access to advanced imaging that affect uptake rates and the emphasis on modular system designs that accommodate diverse practice settings.

Asia-Pacific markets demonstrate accelerating clinical volume and an expanding base of trained operators, driven in part by demographic shifts and growing prevalence of complex coronary disease. Local manufacturing initiatives and regional partnerships in this geography have shortened supply chains and introduced price-competitive alternatives, influencing device portfolios available to cardiac programs. Across all regions, cross-border collaboration on training, combined with remote proctoring and digital education, is contributing to a more even distribution of procedural expertise and an expanding cohort of clinicians proficient in plaque modification techniques.

Competitive and strategic company-level trends emphasizing product differentiation, partnerships, evidence generation, and lifecycle support across device portfolios

Competitive dynamics in the device landscape are driven by incremental product innovation, strategic partnerships, and targeted commercialization efforts that prioritize procedural compatibility and clinician usability. Manufacturers are competing on aspects such as burr material science, delivery catheter flexibility, and interfaces that integrate with imaging platforms to provide real-time feedback during lesion preparation. These capabilities are increasingly central to product differentiation as clinical teams seek devices that reduce procedural time, enhance safety margins, and integrate into existing cath lab workflows.

In addition, strategic alliances between device developers, imaging providers, and distribution partners enable bundled offerings that simplify procurement and training for hospital systems. Industry participants are investing in evidence generation and in educational initiatives to demonstrate technique reproducibility and to expand the pool of operators competent in rotational atherectomy. As competitive intensity grows, there is a parallel focus on lifecycle management, aftermarket support for single-use components, and services that reduce total procedural complexity for high-volume cardiac centers.

Actionable recommendations for device makers and health systems to prioritize innovation, clinician training, contractual flexibility, and supply chain resilience for sustained adoption

Industry leaders should prioritize initiatives that enhance device compatibility with advanced imaging, streamline operator workflows, and secure resilient supply chains that mitigate trade-related disruptions. Investment in clinician education, including hands-on simulation and remote proctoring, will accelerate safe adoption and create centers of excellence that can serve as reference sites for broader rollout. From a commercial standpoint, building flexible contracting models and value-based propositions that address total procedural costs and clinical outcomes will strengthen positioning with hospital procurement teams.

Operationally, executives should evaluate geographic manufacturing footprints and logistics partners to reduce exposure to tariff volatility while preserving the ability to scale production. Product teams ought to continue refining burr geometry and accessory ergonomics to address a spectrum of lesion morphologies and care settings, with particular attention to disposables that impact procedure throughput. Finally, fostering collaborative research with clinical leaders to publish real-world evidence will support credibility and inform guideline-consistent adoption pathways across acute and elective care environments.

Robust mixed-methods research protocol combining primary clinician engagement, secondary clinical literature review, and data triangulation to ensure analytical rigor

The research approach combined structured primary engagement with interventional cardiologists, cath lab managers, and procurement leaders with targeted secondary analysis of clinical literature, device regulatory filings, and procedural guidelines. Primary inputs included in-depth interviews and structured questionnaires designed to elicit qualitative insights on clinical decision drivers, device preferences, and operational constraints. Secondary sources were reviewed to corroborate clinical pathways, technology specifications, and regulatory trends, with attention to peer-reviewed evidence and consensus statements that inform best practices.

Data integrity was ensured through triangulation across multiple information streams, reconciliation of interview findings with published procedural literature, and iterative validation with domain experts. Analytical steps included thematic coding of qualitative responses, cross-segmentation synthesis to surface actionable insights, and sensitivity checks to ensure that conclusions were robust to differing clinical perspectives. Ethical safeguards and confidentiality protocols governed primary data collection, ensuring candid input from stakeholders and protecting commercially sensitive information.

Concluding synthesis of clinical, technological, and commercial dynamics that define the present and near-term trajectory of coronary rotational atherectomy

In summary, percutaneous transluminal coronary rotational atherectomy occupies an increasingly important role in the management of complex calcified coronary disease, supported by iterative device refinements, enhanced imaging integration, and expanding clinician expertise. The confluence of product innovation, procedural standardization, and evolving procurement dynamics is reshaping how providers select and implement plaque modification strategies across diverse care settings. Stakeholders who align product development with clinician needs, invest in scalable training, and proactively address supply chain vulnerabilities will be best positioned to deliver clinical value and operational continuity.

As the clinical community continues to refine indications and optimize technique, ongoing collaboration between device makers, clinical leaders, and health system purchasers will be essential. This collaborative approach will facilitate the translation of technical advances into measurable improvements in procedural success, patient safety, and resource efficiency, thereby supporting the broader adoption of lesion-specific strategies for challenging coronary anatomies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Flush Cassettes
    • 8.1.2. Guide Wires
    • 8.1.3. Rotational Adapters
  • 8.2. Atherectomy Burrs
    • 8.2.1. Large Burrs
    • 8.2.2. Medium Burrs
    • 8.2.3. Small Burrs
  • 8.3. Atherectomy Systems

9. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Lesion Type

  • 9.1. Mild Calcification
  • 9.2. Moderate Calcification
  • 9.3. Non Calcified Lesions
  • 9.4. Severe Calcification

10. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Specialty Clinics
  • 10.3. Hospitals

11. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Indication

  • 11.1. Nstemi
  • 11.2. Stable Angina
  • 11.3. Stemi
  • 11.4. Unstable Angina

12. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Percutaneous Transluminal Coronary Rotational Atherectomy Market

16. China Percutaneous Transluminal Coronary Rotational Atherectomy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Avinger, Inc.
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Cardiovascular Systems, Inc.
  • 17.10. Cook Medical LLC
  • 17.11. INVAMED
  • 17.12. Koninklijke Philips N.V.
  • 17.13. Medtronic PLC
  • 17.14. NEScientific, Inc
  • 17.15. NIPRO CORPORATION
  • 17.16. RA Medical Systems, Inc.
  • 17.17. Rotarex, SA by Becton, Dickinson and Company
  • 17.18. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 165. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)